Back

Statin and risk of dementia in patients with heart failure

25 August 2023 (17:15 - 17:50)
Organised by: Logo
Congress Presentation Part of: Pharmacological therapy in heart failure (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Qingwen Ren

The University of Hong Kong, Hong Kong (Hong Kong)

6 More presentations in this session

Presentation thumbnail
Initiation, titration, and discontinuation - utilization of heart failure medicines in England (EVOLUTION HF UK)
Doctor R. Zhang (London, GB)
Abstract Slides Video
Presentation thumbnail
Soluble guanylate cyclase in heart failure: A network meta-analysis and subgroup analyses of reduced and preserved ejection fraction.
Doctor M. Ibrahim (Flint, US)
Abstract Slides Video
Presentation thumbnail
Feasibility, efficacy and safety of early and rapid initiation of evidence-based treatment for patients with HFrEF- a real world experience of the "four drugs in four weeks" strategy
Doctor S. Sze (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Impact of pharmacological treatment for heart failure after myocardial recovery in arrhythmia-induced cardiomyopathy.
Mr L. Dominguez Rodriguez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Timing of angiotensin receptor-neprilysin inhibitor initiation in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry
Professor L. Lund (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacological therapy in heart failure (2)

The Event

Event poster

ESC Congress 2023

25 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Metformin associated lower risk of dementia among heart failure patients: a population-based retrospective cohort study
thumbnail
Congress Presentation
Incidence and outcomes of dementia after a diagnosis of heart failure: a population-based study
thumbnail
Congress Presentation
The relationship between chronic heart failure, cognitive decline and subclinical atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources